Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PLA2G10HP is a pseudogene derived from or homologous to phospholipase A2 group X (PLA2G10). Pseudogenes are genomic DNA sequences similar to functional genes but are generally non-expressive and do not produce a functional protein. PLA2G10HP is not catalytically active and does not participate in known cellular, pharmacological, or disease processes. By contrast, the active enzyme PLA2G10 is a secreted phospholipase A2 involved in hydrolyzing membrane phospholipids and is implicated in inflammation and lipid mediator production[1][2]. PLA2G10HP should not be confused with PLA2G10, which is the functional gene and enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phospholipase A2 group XH, pseudogene (PLA2G10HP).